|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gastrointestinal leiomyosarcomas:experience of 14 cases and review of published reports显示文摘 | SAVVAS P PENELOPE P VASSILIOS K | 1998 | Eur J Surg1998,16,4: | 1 |
| 2 | Blueberry fruit response to postharvest application of ultraviolet radiation显示文摘 | Penelope P V Julie K C Luke H | 2008 | Postharvest Biology and Technology2008,47,3: | 1 |
| 3 | Strategies for Introducing Wolbachia to Reduce Transmission of Mosquito - Borne Diseases 显示文摘 | Penelope A Hancock Steven P Sinkins | 2011 | PLoS2011,,5: | 1 |
| 4 | Blueberry fruit response topostharvest application of ultraviolet radiation显示文摘 | PENELOPE P V JULIE K C LUKE H | 2008 | Postharvest Biologyand Technology2008,47,: | 1 |
| 5 | Epidemiology and outcomes of acute liver failure in Australia显示文摘BACKGROUND Acute liver failure (ALF) is a life-threatening syndrome with varying aetiologies requiring complex care and multidisciplinary management. Its changing incidence, aetiology and outcomes over the last 16 years in the Australian context remain uncertain. AIM To describe the changing incidence, aetiology and outcomes of ALF in South Eastern Australia. METHODS The database of the Victorian Liver Transplant Unit was interrogated to identify all cases of ALF in adults (> 16 years) in adults hospitalised between January 2002 and December 2017. Overall, 169 patients meeting criteria for ALF were identified. Demographics, aetiology of ALF, rates of transplantation and outcomes were collected for all patients. Transplant free survival and overall survival (OS) were assessed based on survival to discharge from hospital. Results were compared to data from a historical cohort from the same unit from 1988- 2001. RESULTS Paracetamol was the most common aetiology of acute liver failure, accounting for 50% of cases, with an increased incidence compared with the historical cohort (P = 0.046). Viral hepatitis and non-paracetamol drug or toxin induced liver injury accounted for 15% and 10% of cases respectively. Transplant free survival (TFS) improved significantly compared to the historical cohort (52% vs 38%, P = 0.032). TFS was highest in paracetamol toxicity with spontaneous recovery in 72% of cases compared to 31% of non-paracetamol ALF (P < 0.001). Fifty-nine patients were waitlisted for emergency liver transplantation. Nine of these died while waiting for an organ to become available. Forty-two patients (25%) underwent emergency liver transplantation with a 1, 3 and 5 year survival of 81%, 78% and 72% respectively. CONCLUSION Paracetamol toxicity is the most common aetiology of ALF in South-Eastern Australia with a rising incidence over 30 years. TFS has improved, however it remains low in non-paracetamol ALF. | Penelope Hey Timothy P Hanrahan Marie Sinclair Adam G Testro Peter W Angus Adam Peterson Stephen Warrillow Rinaldo Bellomo Marcos V Perini Graham Starkey Robert M Jones Michael Fink Tess McClure Paul Gow | 2019 | World Journal of Hepatology2019,11,7: | 1 |
| 6 | Mitosin and DNA topoisomerase Ⅱα:Two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival显示文摘 | PENELOPE K EFSTRATION P ANASTASIA E | 2001 | Appl Immunohistochem Mol Morphol2001,9,3: | 1 |
| 7 | Lycopene content of mini watermelon varieties grown at four locations 显示文摘 | Penelope P V Julie C Richard H | 2005 | HortScience2005,40,4: | 1 |
| 8 | Mitosin and DNA topoisomerase Ⅱα:Two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival显示文摘 | Penelope K Efstratios P Anastasia E | 2001 | Applied Immunohistochemistry & Molecular Morphology2001,9,3: | 1 |
| 9 | Mitosin and DNA topoisomerase Ⅱ α:Two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival显示文摘 | PENELOPE K M D Efstratios P M D Anastasia E M D | 2001 | Applied Immunohistochemistry & Molecular Morphology2001,9,3: | 1 |
| 10 | Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients显示文摘BACKGROUND Pre-transplant muscle wasting measured by computed tomography has been associated with adverse clinical outcomes after liver transplantation including increased rates of sepsis and hospitalisation days.Upper limb lean mass(LM)measured by dual-energy X-ray absorptiometry(DEXA)was recently identified as a novel predictor of sarcopenia-associated mortality in men waitlisted for transplantation.AIM To investigate the use of DEXA LM in predicting gender-stratified early posttransplant outcomes.METHODS Liver transplant recipients who underwent pre-transplant DEXA body composition imaging between 2002 and 2017 were included.Endpoints included posttransplant mortality and graft failure,bacterial infections,acute cellular rejection(ACR)and intensive care and total hospital length of stay.RESULTS Four hundred and sixty-nine patients met inclusion criteria of which 338 were male(72%).Median age was 55.0 years(interquartile range 47.4,59.7)and model for end-stage liver disease(MELD)score 16.Median time from assessment to transplantation was 7 mo(3.5,12).Upper limb LM was inversely associated with bacterial infections at 180 d post-transplant(hazard ratio=0.42;95%confidence interval:0.20-0.89;P=0.024)in males only.There was a negative correlation between upper limb LM and intensive care(τb=-0.090,P=0.015)and total hospital length of stay(τb=-0.10,P=0.0078)in men.In women,neither MELD nor body composition parameters were associated with post-transplant adverse outcomes or increased length of stay.Body composition parameters,MELD and age were not associated with 90-d mortality or graft failure in either gender.There were no significant predictors of early ACR.CONCLUSION Sarcopenia is an independent and potentially modifiable predictor of increased post-transplant bacterial infections and hospital length of stay in men with cirrhosis.DEXA upper limb LM provides a novel measure of muscle wasting that has prognostic value in this cohort.The lack of association in women requires further investigation. | Penelope Hey Rudolf Hoermann Paul Gow Timothy P Hanrahan Adam G Testro Ross Apostolov Marie Sinclair | 2022 | World Journal of Transplantation2022,12,6: | 0 |